Company & Sponsor Intelligence

University of Kansas Medical Center

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials9

Recruiting1

Completed8

Countries1

Therapeutic footprint

alzheimersautismparkinsons

Indexed studies

NCT02921672Feasibility Trial of a Mediterranean Diet Pattern to Prevent Cognitive Decline
alzheimers · United StatesNA

NCT01741701A Pilot Study of Oxaloacetate in Subjects With Treated PD
parkinsons · United StatesPHASE2, PHASE3

NCT02000583Alzheimer's Prevention Through Exercise
alzheimers · United StatesNA

NCT07463755Low-Fidelity Driving Simulator Training in Parkinson's Disease.
parkinsons · United StatesNA

NCT05277103Exploring Predictors of Response to a Peer-Mediated Intervention for Preschoolers With ASD
autism · United StatesNA

NCT03954210SIESTA: Sleep Intervention to Enhance Cognitive Status and Reduce Beta Amyloid
alzheimers · United StatesNA

NCT02928068Telehealth Coaching for Families of Children With Autism
autism · United StatesNA

NCT06640842Brain Health in Midlife
alzheimers · United StatesCOMPLETED

NCT05207397Lactate for Energy and Neurocognition
alzheimers · United StatesCOMPLETED

Intelligence layer updated: 2026-10-14 06:11:28.884102+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →